🔎 Trials Near Me

Akèy › Limfom Selil-T › Florid

Etid klinik pou Limfom Selil-T nan Florid

8 etid pou Limfom Selil-T ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  • Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06561048

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

  • Mayo Clinic in Florida, Jacksonville
  • Moffitt Cancer Center-International Plaza, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06724237

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04803201

CD4CAR for CD4+ Leukemia and Lymphoma

  • University of Miami Sylvester Comprehensive Cancer Center, Miami
Ap rekriteFaz 1
Laj 12 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT03829540

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

  • Florida Cancer Specialists, Sarasota
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT05463263

A Registry for People With T-cell Lymphoma

  • University of Miami (Data Collection Only), Miami
  • Moffitt Cancer Center (Data Collection Only), Tampa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

  • Moffitt Cancer Center Magnolia Campus, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 3, 2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • University of Miami, Miami
Ap rekriteFaz 1
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.